2017-05-12T12:56:15-05:00 2016-06-30 346565596 ERNST & YOUNG US LLP 201 NORTH FRANKLIN STREET SUITE 2400 TAMPA FL 33602 990 2015-07-01 592451713 H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE INC HLEE 8137454673 12902 MAGNOLIA DRIVE TAMPA FL 33612 YVETTE M LYONS TREMONTI EVP/CFO 8137457862 2017-05-12 1 MELANIE A MCPEAK P01346034 8132254800 2015 2021-01-29 14:40:06Z ALAN F LIST MD 12902 MAGNOLIA DRIVE TAMPA FL 33612 222752355 0 X WWW.MOFFITT.ORG X 1984 FL TO PROMOTE AND SUPPORT THROUGH RESEARCH, MANAGEMENT AND OTHER MEANS OF SUPPORT. 21 20 1761 345 241133 148 124702019 132852458 2627936 2221956 1471223 5334488 17699978 4000506 146501156 144409408 1113400 757818 0 0 86796161 90029311 0 0 0 55283821 67174881 143193382 157962010 3307774 -13552602 773774141 778289227 399027523 389321274 374746618 388967953 X SEE SCHEDULE OTO PROMOTE AND SUPPORT H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE LIFETIME CANCER SCREENING CENTER, AND H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE FOUNDATION THROUGH RESEARCH, MANAGEMENT AND OTHER MEANS OF SUPPORT. 0 0 105495672 757818 2846406 SEE SCHEDULE OTHE H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. IS A RECOGNIZED LEADER IN FOCUSED, INNOVATIVE CANCER RESEARCH, A MAJOR REGIONAL ONCOLOGY REFERRAL CENTER, AND A NATIONAL CANCER INSTITUTE DESIGNATED COMPREHENSIVE CANCER CENTER.BASED ON ITS SINGULAR MISSION - TO CONTRIBUTE TO THE PREVENTION AND CURE OF CANCER - THE CANCER CENTER'S RESEARCH ACTIVITIES RELATE PRIMARILY TO THE AREAS OF BASIC SCIENCE, CANCER PREVENTION AND CONTROL, TRANSLATIONAL SCIENCE, PRE-CLINICAL AND CLINICAL INVESTIGATIONS, AND PROVIDING MANAGEMENT AND OTHER SUPPORT SERVICES AS THE SOLE CORPORATE MEMBER AND PARENT FOR THE FOLLOWING SUBSIDIARY CORPORATIONS: H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. (THE HOSPITAL) WHICH PROVIDES MEDICAL AND HOSPITAL CARE, MEDICAL EDUCATION AND TRAINING, AND CLINICAL (PATIENT-RELATED) RESEARCH IN MAINTAINING HEALTH, AND PREVENTING, DETECTING, AND TREATING CANCER;H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE LIFETIME CANCER SCREENING CENTER, INC. (MOFFITT MEDICAL GROUP) WHICH EMPLOYS AND MANAGES PHYSICIANS AND OTHER MEDICAL PROFESSIONALS WHO STAFF THE HOSPITAL, AND PROVIDE CLINICAL RESEARCH SERVICES TO THE CANCER CENTER; ANDH. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE FOUNDATION, INC. (THE FOUNDATION) WHICH IS THE PRINCIPAL FUND-RAISING ORGANIZATION FOR THE CANCER CENTER AND ITS SUBSIDIARIES.THE CANCER CENTER'S MULTIDISCIPLINARY CLINICAL PROGRAM STRUCTURE AND OPEN LABORATORY ARCHITECTURE PROVIDE AN ENVIRONMENT CONDUCIVE FOR TRAINING FUTURE SCIENTIFIC AND CLINICAL LEADERS IN ONCOLOGY, AND REFLECT THE CANCER CENTER'S COMMITMENT TO COLLABORATION IN ALL ASPECTS OF CANCER RESEARCH. 105495672 1 1 0 1 0 0 0 0 0 0 1 0 0 1 1 1 0 1 0 0 0 0 0 0 0 0 0 1 0 1 1 0 0 0 0 0 0 0 0 1 1 1 0 0 0 0 1 1 1 0 0 1 382 0 1 1761 1 1 1 0 0 0 0 0 0 0 0 0 X 21 20 1 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 1 0 X YVETTE M LYONS TREMONTI 8137457862 12902 MAGNOLIA DR TAMPA FL 33612 X ROBERT ROTHMAN DIRECTOR, CHAIR 1.00 1.00 X X 0 0 0 SENATOR CONNIE MACK DIRECTOR, IMMEDIATE PAST CHAIR 1.00 1.00 X X 0 0 0 TIMOTHY J ADAMS DIRECTOR, VICE CHAIR 1.00 1.00 X X 0 0 0 BENJAMIN H HILL III ESQ DIRECTOR, SECRETARY/TREASURER 1.00 1.00 X X 0 0 0 CARLOS ALFONSO DIRECTOR 1.00 0.00 X 0 0 0 ANGELA BIEVER DIRECTOR 1.00 0.00 X 0 0 0 THE HONORABLE CARL CARPENTER DIRECTOR 1.00 0.00 X 0 0 0 THEODORE J COUCH SR DIRECTOR 1.00 1.00 X 0 0 0 EDWARD DEBARTOLO DIRECTOR 1.00 0.00 X 0 0 0 DAN DOYLE DIRECTOR 1.00 0.00 X 0 0 0 EDWARD C DROSTE DIRECTOR 1.00 1.00 X 0 0 0 CECELIA D FERMAN DIRECTOR 1.00 0.00 X 0 0 0 JUDY L GENSHAFT PHD DIRECTOR 1.00 0.00 X 0 0 0 THE HONORABLE JOHN A GRANT DIRECTOR 1.00 0.00 X 0 0 0 THE HONORABLE JAMES T HARGRETT DIRECTOR 1.00 0.00 X 0 0 0 BETH A HOUGHTON DIRECTOR 1.00 1.00 X 0 0 0 THE HONORABLE H LEE MOFFITT DIRECTOR 1.00 4.00 X 0 0 0 JOHN RAMIL DIRECTOR 1.00 0.00 X 0 0 0 FRANCISCO SANCHEZ DIRECTOR 1.00 0.00 X 0 0 0 LIZ SMITH DIRECTOR 1.00 0.00 X 0 0 0 JOHN TOMLIN DIRECTOR 1.00 0.00 X 0 0 0 ALAN F LIST PRES/CEO 44.00 11.00 X 2904711 0 76128 LOUIS D DE LA PARTE EVP GEN COUNS & ASST SEC 22.00 33.00 X 610363 0 50636 JOHN A KOLOSKY EVP COO 24.00 31.00 X 942465 0 94556 G DOUGLAS LETSON EVP-PIC 11.00 44.00 X 0 833151 49115 THOMAS A SELLERS EVP CNT DIR, DIR-MRI 55.00 0.00 X 855606 0 48192 YVETTE M LYONS TREMONTI EVP-CFO & ASST TREAS 22.00 33.00 X 653701 0 51585 LYNN C MOSCINSKI CHIEF ACADEMIC OFFICER 1.00 54.00 X 0 619187 37132 MARK F HULSE SVP CHIEF ADMIN OFFICER TO 11/24/15 55.00 0.00 X 505120 0 66787 MARIANA BUGALLO-MUROS VP CHIEF HR OFFICER 55.00 0.00 X 184082 0 8630 DONALD FUTRELL VP FACILITIES & SUPPORT SVC 55.00 0.00 X 317201 0 33572 B LEE GREEN VP DIVERSITY AND COMMUNITY RELATIONS 55.00 0.00 X 350753 0 47310 JENNIFER GREENMAN VP & CIO 55.00 0.00 X 320434 0 37222 DIANE HAMMON VP STRATEGIC DEVELOPMENT 55.00 0.00 X 332497 0 42382 TRACY N PETERSON VP DEPUTY GENERAL COUNSEL 55.00 0.00 X 281199 0 45374 DANA E ROLLISON VP CHIO 55.00 0.00 X 336935 0 36636 BRIAN SPRINGER VP RESEARCH ADMIN 55.00 0.00 X 368298 0 26928 W J WILSON VP GOVT RELATIONS 55.00 0.00 X 320736 0 36165 KAREN FIELDS MED DIR, STRATEGIC ALLIANC 50.00 0.00 X 393262 0 49147 JOHN L CLEVELAND ACD BASIC SCIENCE NFGC 50.00 0.00 X 505742 0 42275 JULIE Y DJEU ACD RESEARCH EDUCATION 50.00 0.00 X 414922 0 64611 PAUL JACOBSEN ACD FOR POPULATION SCIENCE 50.00 0.00 X 438621 0 45941 SHENG WEI SR MBR FACULTY IMMUNOLOGY 50.00 0.00 X 1671887 0 27536 JANENE J CULUMBER FORMER SVP FIN & PAYOR STRAT 0.00 0.00 X 130196 0 0 WILLIAM S DALTON FORMER PRES-CEO;CTR DIR TO 0.00 55.00 X 0 1097768 53801 DORTE HEIMBECK FORMER INT VP HR 50.00 0.00 X 185609 0 20981 JAMES J MULAY FORMER EVP APPL SC & ACD T 54.00 1.00 X 557052 0 41148 JOANNE L OLSON FORMER VP HR 0.00 0.00 X 105229 0 10619 DANIEL M SULLIVAN FORMER EVP ACD CLINICAL IN 0.00 50.00 X 0 641485 34543 13686621 3191591 1178952 182 1 1 0 SHUMAKER LOOP & KENDRICK LLP 101 E KENNEDY BLVD STE 2800 TAMPA FL 33602 LEGAL SERVICES 1715404 FREEDOM SOLUTIONS LLC PO BOX 47765 TAMPA FL 33646 IT SERVICES 1593747 BERKELEY RESEARCH GROUP LLC 2200 POWELL STREET STE 1200 EMERYVILLE CA 94608 CONSULTING SERVICES 578515 ESCOT BUS LINES 6890 142ND AVE NORTH LARGO FL 33771 TRANSPORTATION SERVICES 503541 THEO EXECUTIVE GROUP LLC 909 LAKE CAROLYN PARKWAY IRVING TX 75039 ADVISORY SERVICES 461382 33 13954763 87974312 30923383 1498283 132852458 CORE LAB REVENUE 900099 1268300 1268300 AFFILIATE SERVICES 900099 591624 591624 INTERNATIONAL COLLAB 900099 150000 150000 CYCLOTRON 900099 120000 120000 REIMBURSEMENTS 541900 42548 42548 49484 49484 2221956 2390000 2390000 624450 624450 80640402 22583 78189580 153367 2450822 -130784 2320038 2320038 PARKING 900099 1043690 1043690 PREMIER PARTNERSHIP 900099 940871 15896 924975 REV RECOG OF PY LIABIL 900099 584843 584843 1431102 225237 1205865 4000506 144409408 2846406 241133 8469411 X 757818 757818 8203389 1291135 6912254 869853 869853 66352844 50294517 16058327 3741493 2593280 1148213 6308068 4565553 1742515 4553664 3057783 1495881 1260852 1260852 80658 80658 124051 124051 339410 339410 2739930 1331341 1408589 1572351 11311 1561040 12400770 8247482 4153288 1506514 1506514 6323408 1010599 5312809 1359693 1060227 299466 804312 804312 8670939 1249 8669690 82816 82816 ALLOC OF INTERCO EXP 0 17578203 -17578203 PURCHASED SERVICES 10344244 5287896 5056348 INTERCOMPANY REVENUE AC 6509395 6509395 SUBCONTRACTS 3917031 3917031 9138507 4490247 4648260 157962010 105495672 52466338 0 124618169 146542376 1053068 1915239 11452601 13246995 6594525 11266243 727146840 366075713 353385505 361071127 276670273 244247247 773774141 778289227 79727108 81851647 8471803 7052737 302159257 292164560 8669355 8252330 399027523 389321274 X 325698635 337879742 49047983 51088211 374746618 388967953 773774141 778289227 X -13552602 -4506138 32280075 X 0 1 X 1 1 1 X 101384269 93306736 101277491 124702019 132852458 553522973 101384269 93306736 101277491 124702019 132852458 553522973 553522973 2306128 3974245 3911053 2520087 3014450 15725963 51506 70493 23642 20258 15896 181795 1513990 2207626 2200564 17397496 3759373 27079049 596509780 11226425 0.92790 0.93030 X Schedule A, Part II, Line 10, Explanation of Other Income: CIGARETTE TAX PROCEEDS - 2011 Amount: $ 877995. 2012 Amount: $ 657163. 2013 Amount: $ 668365. 2014 Amount: $ 962301. 2015 Amount: $ 0. LICENSE FEES - 2011 Amount: $ 310312. 2012 Amount: $ 190434. 2013 Amount: $ 138078. 2014 Amount: $ 13859061. 2015 Amount: $ 282908. PARKING - 2012 Amount: $ 1045114. 2013 Amount: $ 1093542. 2014 Amount: $ 1079147. 2015 Amount: $ 1043690. EYE INSTITUTE REIMBURSEMENT - 2012 Amount: $ 148051. 2013 Amount: $ 138490. 2014 Amount: $ 143888. 2015 Amount: $ 127560. LEASES - 2012 Amount: $ 59455. 2013 Amount: $ 1639. 2014 Amount: $ 5578. 2015 Amount: $ 48351. STAFF RETAIL SERVICES - 2012 Amount: $ 29107. 2013 Amount: $ 83842. 2014 Amount: $ 107450. 2015 Amount: $ 41892. SETTLEMENT - 2014 Amount: $ 728402. SUPPORT ACCOUNTS - 2015 Amount: $ 415730. REBATES - 2015 Amount: $ 116048. PREMIER PARTNERSHIP - 2015 Amount: $ 924975. REV RECOG OF PRIOR YEAR LIABILITY - 2015 Amount: $ 584843. INTEREST FROM CONTROLLED ORG - 2015 Amount: $ 152860. MISC - 2011 Amount: $ 325683. 2012 Amount: $ 78302. 2013 Amount: $ 76608. 2014 Amount: $ 511669. 2015 Amount: $ 20516. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 1 1 0 1 7425 1 28012 0 1 155118 1 6642 1 4788 201985 0 Part II-B, Line 1: THE H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. AND ITS THREE NON-PROFIT SUBSIDIARY CORPORATIONS ("CORPORATION") WERE CREATED TO GOVERN AND OPERATE THE H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE ("INSTITUTE") PURSUANT TO SECTION 1004.43, FLORIDA STATUTES. AMONG OTHER THINGS, SECTION 1004.43, FLORIDA STATUTES PROVIDES: (1) THAT THE CORPORATION SHALL ENTER INTO AN AGREEMENT WITH THE STATE BOARD OF EDUCATION FOR THE UTILIZATION OF FACILITIES ON THE CAMPUS OF THE UNIVERSITY OF SOUTH FLORIDA; (2) THAT THE CORPORATION SUBMIT ANNUAL POST AUDITS OF ITS FINANCIAL ACCOUNTS TO THE AUDITOR GENERAL OF THE STATE OF FLORIDA AND THE BOARD OF GOVERNORS FOR THEIR REVIEW; AND (3) THAT THE CORPORATION'S CEO REPORT TO THE BOARD OF GOVERNORS OR ITS DESIGNEE AND PROVIDE COPIES OF THE INSTITUTE'S ANNUAL REPORT TO THE GOVERNOR OF THE STATE OF FLORIDA, THE CABINET, THE PRESIDENT OF THE SENATE, THE SPEAKER OF THE HOUSE AND THE CHAIR OF THE BOARD OF GOVERNORS. ALTHOUGH THE CORPORATION IS A PRIVATE ENTITY, IT IS NONETHELESS SUBJECT TO THE STATE OF FLORIDA'S PUBLIC RECORDS AND THE PUBLIC MEETINGS LAWS. THE CORPORATION ALSO RELIES ON ANNUAL APPROPRIATIONS BY THE LEGISLATURE OF THE STATE OF FLORIDA AND GRANTS FROM VARIOUS LOCAL, STATE AND FEDERAL AGENCIES FOR OPERATION AND MAINTENANCE OF ITS FACILITIES AND FOR SPECIFIC RESEARCH AND CLINICAL PROGRAMS. FOR THESE REASONS, THE CORPORATION FROM TIME TO TIME ENGAGES LOBBYISTS AND OTHER CONSULTANTS; (1) TO ASSIST IT IN COMPLYING WITH ITS REPORTING REQUIREMENTS TO THE STATE OF FLORIDA UNDER SECTION 1004.43, FLORIDA STATUTES; (2) TO MONITOR LEGISLATIVE AND EXECUTIVE BRANCH ACTION AT LOCAL, STATE AND FEDERAL LEVELS OF GOVERNMENT WHICH IMPACT ITS OPERATION AND THE FULFILLMENT OF ITS MISSION; AND (3) TO INFLUENCE LEGISLATION IN FURTHERANCE OF ITS MISSION IN THE AREAS OF CANCER RESEARCH AND TREATMENT, THE TEACHING AND TRAINING OF HEALTH CARE PROFESSIONALS AND COMMUNITY EDUCATION AND OUTREACH ACTIVITIES. THE CORPORATION DOES NOT ENGAGE IN ANY ACTIVITIES TO SUPPORT OR OPPOSE ANY CANDIDATE FOR PUBLIC OFFICE. OTHER ACTIVITIES, LINE 1i THE OTHER ACTIVITIES AMOUNT LISTED ON LINE 1i IS COMPRISED OF EXPENSES RELATED TO ORCHESTRATING CONTACT BETWEEN GRASSROOTS SUPPORTERS AND ELECTED OFFICIALS TO PROMOTE THE INSTITUTION'S LEGISLATIVE INITIATIVES. 9306184 9306184 448281588 165761427 282520161 8415660 3999396 4416264 248706740 196314890 52391850 12436668 12436668 361071127 BOND ISSUE COSTS 1501631 INTEREST IN NET ASSETS OF FOUNDATION 33201910 ASSETS WHOSE USE IS LIMITED 178907224 RECEIVABLES FROM CONTROLLED ORGS 22007189 OTHER RECEIVABLES 8059575 OTHER ASSETS 69618 INVESTMENT IN MTC 500000 INVESTMENT IN M2GEN 100 244247247 LEASE OBLIGATIONS 6255686 OTHER LIABILITIES 1996644 8252330 X Part X, Line 2: THE CANCER CENTER RECOGNIZES UNCERTAIN TAX POSITIONS WHEN IT IS MORE LIKELY THAN NOT (I.E., GREATER THAN 50% LIKELIHOOD OF RECEIVING BENEFIT) AND RECORDS THESE BENEFITS AT THE AMOUNT MOST LIKELY TO BE REALIZED ASSUMING A REVIEW BY TAX AUTHORITIES HAVING ALL RELEVANT INFORMATION AND APPLYING CURRENT CONVENTIONS. THE CANCER CENTER HAS NO SIGNIFICANT UNRECOGNIZED TAX BENEFITS AND DOES NOT BELIEVE THAT THERE WILL BE ANY MATERIAL CHANGES IN THE CANCER CENTER'S UNRECOGNIZED TAX POSITION OVER THE NEXT 12 MONTHS. 1 AMERICAN CANCER SOCIETY INC 250 WILLIAMS STREET NW SUITE 400 ATLANTA GA 30303 131788491 501(C)(3) 26000 SPONSORSHIP AMERICAN SOCIETY FOR MICROBIOLOGY 1752 N STREET NW WASHINGTON DC 20036 381616141 501(C)(3) 10000 SPONSORSHIP ASSOCIATION OF ONCOLOGY SOCIAL WORK 17W110 22ND STREET STE 800 OAKBROOK TERRACE IL 60181 133736895 501(C)(3) 10000 SPONSORSHIP BIOFLORIDA 525 OKEECHOBEE BLVD SUITE 1500 WEST PALM BEACH FL 33401 593436638 11250 SPONSORSHIP CENTER FOR BUILDING HOPE 5481 COMMUNICATIONS PARKWAY SARASOTA FL 34240 650495067 501(C)(3) 7500 SPONSORSHIP DEBARTOLO FAMILY FOUNDATION INC 15436 N FLORIDA AVENUE SUITE 200 TAMPA FL 33613 311739677 501(C)(3) 12000 SPONSORSHIP GREATER TAMPA CHAMBER OF COMMERCE INC 201 N FRANKLIN STREET SUITE 201 TAMPA FL 33602 590474960 501(C)(6) 14000 SPONSORSHIP HILLSBOROUGH EDUCATION FOUNDATION INC 2306 N HOWARD AVENUE TAMPA FL 33607 592883361 501(C)(3) 6000 SPONSORSHIP INSTITUTE FOR PATIENT & FAMILY CENTERED CARE 6917 ARLINGTON ROAD SUITE 309 BETHESDA MD 20814 521777133 501(C)(3) 25000 SPONSORSHIP KAY YOW CANCER FUND 5121 KINGDOM WAY SUITE 305 RALEIGH NC 27607 261789695 501(C)(3) 6000 SPONSORSHIP MARTIN HEALTH FOUNDATION PO BOX 9010 STUART FL 34995 592307522 501(C)(3) 10000 SPONSORSHIP PANCREATIC CANCER ACTION NETWORK 1500 ROSECRANS AVENUE SUITE 200 MANHATTAN BEACH CA 90266 262408330 501(C)(3) 7500 SPONSORSHIP PEDIATRIC CANCER FOUNDATION 5500 W EXECUTIVE DRIVE SUITE 300 TAMPA FL 33609 593097333 501(C)(3) 20000 SPONSORSHIP TAMPA INNOVATION ALLIANCE INC 3100 E FLETCHER AVENUE TAMPA FL 33613 611692291 501(C)(6) 50000 SPONSORSHIP THE LEUKEMIA & LYMPHOMA SOCIETY INC 1311 MAMARONECK AVENUE WHITE PLAINS NY 10605 135644916 501(C)(3) 20000 SPONSORSHIP THE V FOUNDATION 106 TOWERVIEW COURT CARY NC 27513 133705951 501(C)(3) 25000 SPONSORSHIP H LEE MOFFITT CC&RI HOSPITAL INC 12902 MAGNOLIA DRIVE TAMPA FL 33612 593238634 501(C)(3) 115071 INTERCOMPANY SUPPORT MOFFITT GENETICS CORPORATION 10902 N MCKINLEY DRIVE TAMPA FL 33612 208486180 243654 INTERCOMPANY SUPPORT 14 4 Part I, Line 2: THE SCHEDULE I, PART II, GRANTS LISTED AS SPONSORSHIPS ARE APPROVED THROUGH THE CHECK REQUEST PROCESS. BECAUSE OF THE NATURE OF THE GRANTS, THE GRANT USE IS NOT MONITORED SINCE THEY ARE GIVEN TO THE ORGANIZATION FOR A SPECIFIC PURPOSE OR EVENT. THE GRANTS LISTED AS INTERCOMPANY SUPPORT ARE ONLY MADE TO RELATED ORGANIZATIONS TO SUPPORT THEIR OPERATIONS. X 0 1 X X X X 1 1 0 0 0 1 1 0 0 ALAN F LIST PRES/CEO 780687 0 1949803 0 174221 0 45755 0 37617 0 2988083 0 0 0 LOUIS D DE LA PARTE EVP GEN COUNS & ASST SEC 405550 0 174254 0 30559 0 32202 0 27042 0 669607 0 0 0 JOHN A KOLOSKY EVP COO 600516 0 257315 0 84634 0 75454 0 21083 0 1039002 0 0 0 G DOUGLAS LETSON EVP-PIC 0 543509 0 234075 0 55567 0 26443 0 24402 0 883996 0 0 THOMAS A SELLERS EVP CNT DIR, DIR-MRI 546623 0 235241 0 73742 0 26443 0 23731 0 905780 0 0 0 YVETTE M LYONS TREMONTI EVP-CFO & ASST TREAS 435554 0 186073 0 32074 0 35568 0 22672 0 711941 0 0 0 LYNN C MOSCINSKI CHIEF ACADEMIC OFFICER 0 478210 0 120725 0 20252 0 26442 0 12329 0 657958 0 0 MARK F HULSE SVP CHIEF ADMIN OFFICER TO 11/24/15 311652 0 145029 0 48439 0 43759 0 29839 0 578718 0 0 0 MARIANA BUGALLO-MUROS VP CHIEF HR OFFICER 163262 0 20000 0 820 0 -45 0 15127 0 199164 0 0 0 DONALD FUTRELL VP FACILITIES & SUPPORT SVC 225028 0 83089 0 9084 0 15989 0 26629 0 359819 0 0 0 B LEE GREEN VP DIVERSITY AND COMMUNITY RELATIONS 245081 0 93116 0 12556 0 21917 0 33635 0 406305 0 0 0 JENNIFER GREENMAN VP & CIO 225567 0 83732 0 11135 0 17843 0 24946 0 363223 0 0 0 DIANE HAMMON VP STRATEGIC DEVELOPMENT 242504 0 88547 0 1446 0 18515 0 32382 0 383394 0 0 0 TRACY N PETERSON VP DEPUTY GENERAL COUNSEL 211563 0 69153 0 483 0 15428 0 31136 0 327763 0 0 0 DANA E ROLLISON VP CHIO 242948 0 89589 0 4398 0 16950 0 20902 0 374787 0 0 0 BRIAN SPRINGER VP RESEARCH ADMIN 269764 0 96752 0 1782 0 15500 0 13834 0 397632 0 0 0 W J WILSON VP GOVT RELATIONS 240820 0 68881 0 11035 0 21248 0 22141 0 364125 0 0 0 KAREN FIELDS MED DIR, STRATEGIC ALLIANC 333360 0 56646 0 3256 0 26443 0 24066 0 443771 0 0 0 JOHN L CLEVELAND ACD BASIC SCIENCE NFGC 356144 0 130799 0 18799 0 18513 0 26842 0 551097 0 0 0 JULIE Y DJEU ACD RESEARCH EDUCATION 298339 0 107567 0 9016 0 49578 0 16155 0 480655 0 0 0 PAUL JACOBSEN ACD FOR POPULATION SCIENCE 303114 0 110041 0 25466 0 19950 0 27429 0 486000 0 0 0 SHENG WEI SR MBR FACULTY IMMUNOLOGY 163307 0 1506743 0 1837 0 26443 0 2011 0 1700341 0 0 0 JANENE J CULUMBER FORMER SVP FIN & PAYOR STRAT 0 0 0 0 130196 0 0 0 0 0 130196 0 0 0 WILLIAM S DALTON FORMER PRES-CEO;CTR DIR TO 0 643507 0 408438 0 45823 0 37518 0 26203 0 1161489 0 0 DORTE HEIMBECK FORMER INT VP HR 150412 0 34736 0 461 0 11910 0 9875 0 207394 0 0 0 JAMES J MULAY FORMER EVP APPL SC & ACD T 375807 0 137410 0 43835 0 18443 0 27629 0 603124 0 0 0 JOANNE L OLSON FORMER VP HR 80072 0 0 0 25157 0 8284 0 2738 0 116251 0 0 0 DANIEL M SULLIVAN FORMER EVP ACD CLINICAL IN 0 435609 0 156118 0 49758 0 26442 0 9869 0 677796 0 0 Part I, Line 1b PAYMENTS MADE FOR SOCIAL CLUB DUES ARE APPROVED BY THE JOINT EXECUTIVE COMPENSATION AND BENEFITS COMMITTEE (JEC&BC). PAYMENTS ARE A FIXED AMOUNT BASED ON JOB CLASSIFICATION AND IS DOCUMENTED IN MINUTES OF THE COMMITTEE AND REPORTED BACK TO THE BOARD. Part I, Lines 4a-b IN GENERAL, HOSPITAL OFFERS SEVERANCE PAYMENTS TO TEAM MEMBERS IF THE TEAM MEMBER IS IN A POSITION THAT HAS BEEN ELIMINATED OR REALIGNED. JANENE J. CULUMBER, A FORMER OFFICER, LEFT MOFFITT INSTITUTE, A RELATED ORGANIZATION, ON MAY 25, 2014 AND CONTINUED TO RECEIVED SEVERANCE PAYMENTS OF $130,195.61 ELIGIBILITY TO PARTICIPATE IN/CONTRIBUTE TO THE SUPPLEMENTAL EXECUTIVE RETIREMENT PLAN IS BASED ON JOB POSITION, YEAR'S OF SERVICE AND ANNUAL SALARY THRESHOLD WHICH ASSISTS IN DETERMINING THE TIER FOR WHICH THE TEAM MEMBER IS CLASSIFIED. THE COMPANY'S MATCHING CONTRIBUTION VARIES BETWEEN TIERS. THE FOLLOWING INDIVIDUALS PARTICIPATE IN A SUPPLEMENTAL EXECUTIVE RETIREMENT PLAN AND AMOUNTS LISTED ARE INCLUDED IN THEIR TOTAL COMPENSATION LISTED IN SCH J, PART II, COLUMN B, RESPECTIVELY: YVETTE M. LYONS TREMONTI-$29,772 JANENE J. CULUMBER-$22,882 JOHN A. KOLOSKY-$53,507 BRAULIO VICENTE-$0 LOUIS D. DE LA PARTE-$28,036 G. DOUGLAS LETSON-$44,113 B. LEE GREEN-$0 ALAN F. LIST-$81,565 JAMES J. MULAY-$20,871 THOMAS A. SELLERS-$46,809 W. J. WILSON-$0 WILLIAM S. DALTON-$0 DANIEL M. SULLIVAN-$26,664 MARIA BUGALLO-MUROS-$0 PAUL JACOBSEN-$8553 DANA ROLLISON-$1,253 JULIE DJEU-$0 DIANE HAMMON-$0 MARK HULSE-$0 Part I, Line 6 IN GENERAL, INCENTIVE COMPENSATION IS BASED ON A PERCENTAGE OF MOFFITT'S NET OPERATING INCOME AND ACHIEVEMENT AGAINST SPECIFIC ORGANIZATIONAL GOALS, DIVISIONAL AND/OR INDIVIDUAL GOALS, PROVIDED A CERTAIN NET OPERATING INCOME THRESHOLD IS MET. A HILLSBOROUGH COUNTY INDUSTRIAL DEVELOPMENT AUTHORITY 591293512 43233ADJ2 2007-11-08 118550173 SEE SUPPLEMENTAL SCH K PART VI 0 0 0 B HILLSBOROUGH COUNTY INDUSTRIAL DEVELOPMENT AUTHORITY 591293512 2015-10-06 18440000 SEE SUPPLEMENTAL SCH K PART VI 0 0 0 C CITY OF TAMPA 591101138 875161BN0 2012-11-29 39972900 SEE SUPPLEMENTAL SCH K PART VI 0 0 0 D CITY OF TAMPA 591101138 875282BE4 2012-09-19 144692131 SEE SUPPLEMENTAL SCH K PART VI 0 0 0 A 7950000 126113398 8806625 8332655 1028820 94652670 1571771 11720857 2010 0 0 0 1 B 18440000 18440000 2015 0 0 0 1 C 2885000 39972906 284723 39688177 2012 1 0 1 1 D 5045000 14522703 1176163 92605171 17913907 33531793 2016 1 0 0 1 A 0 0 0 0 0 0 1 B 0 0 1 1 0 0 0 1 C 0 0 1 1 0 0 0 1 D 0 1 1 1 1 1 0 0 1 A 0 0 0 1 0 0 0 0 1 B 0 0 0 1 1 0 0 0 1 C 0 0 0 1 0 0 0 0 1 D 0 0 0 1 0 0 0 0 1 A 1 B 1 C 1 D 1 FORM 990, SCHEDULE K, Part IA column (F) 1) FINANCING THE COST OF CONSTRUCTION AND EQUIPPING A FOUR STORY ADDITION TO THE MAIN CAMPUS OF THE HOSPITAL, TO INCLUDE 36 ADDITIONAL INPATIENT BEDS, RADIATION ONCOLOGY CLINIC PROGRAM EXPANSION WITH THE ADDITION OF TWO NEW VAULTS USED FOR STATE OF THE ART LINEAR ACCELERATORS, CLINICAL LAB AND PATHOLGY PROGRAM EXPANSION, APPROXIMATELY 40,000 GROSS SQUARE FEET OF FACULTY OFFICE SPACE, AND 1,000 SPACE PARKING GARAGE. 2) FINANCING THE COST OF VARIOUS BACKFILL AND REFURBISHMENT PROJECTS, INCLUDING THE ADDITION OF EIGHT INPATIENT BEDS IN EXISTING SPACE LOCATED AT THE INSTITUTE AND HOSPITAL. FORM 990, SCHEDULE K, Part IB column (F) 1)BOND PROCEEDS (SERIES 2010A AND 2010C) WERE USED TO CURRENT REFUND SERIES 2010 BONDS, ISSUED SEPTEMBER 8, 2010. FORM 990, SCHEDULE K, Part IC column (F) 1)PROCEEDS USED TO CURRENT REFUND SERIES 1999A AND 2002C BONDS, ISSUED MARCH 25, 1999 AND NOVEMBER 14, 2002 RESPECTIVELY. FORM 990, SCHEDULE K, Part ID column (F) 1) ACQUISITION, CONSTRUCTION, FURNISHING AND EQUIPPING OF THE MULTI-STORY MCKINLEY CLINICAL RESEARCH FACILITY AND INFRASTRUCTURE THAT WILL CONTAIN AN AMBULATORY SURGERY CENTER, PROCEDURE SUITES, CLINICS, IMAGING, INFUSION, SCREENING AND DRY LAB RESEARCH. 2)CONSTRUCTION, RENOVATION, AND EQUIPPING CLINICAL AND RESEARCH FACILITIES INCLUDING ADDITIONAL BED CAPACITY, OPERATING SUITES AND ASSOCIATED FACILITIES AND INFRASTRUCTURE. 3) A PORTION OF THE 2012A PROCEEDS WAS USED TO CURRENT REFUND 2002A AND 2002B SERIES BONDS, BOTH ISSUED NOVEMBER 14, 2002. FORM 990, SCHEDULE K PART II, LINE 3 THE DIFFERENCE BETWEEN TOTAL PROCEEDS AND ISSUANCE PRICE IS INVESTMENT EARNINGS. SCHEDULE K, PART IV, LINE 2C: MOFFITT CONTRACTS WITH THIRD PARTY TO ANNUALLY CALCULATE ARBITRAGE REBATES. NO REBATES ARE DUE. - KIRA HULSE SEE PART V 46970 SEE PART V 0 SENATOR CONNIE MACK SEE PART V 150000 SEE PART V 0 Form 990, Schedule L, Part IV INTERESTED PERSON: KIRA HULSERELATIONSHIP: DAUGHTER OF MARK F. HULSE, OFFICERTRANSACTION DESCRIPTION: COMPENSATION AS AN EMPLOYEE OF THE ORGANIZATIONINTERESTED PERSON: SENATOR CONNIE MACKRELATIONSHIP: PARTNER WITH LIBERTY PARTNERS, GROUP, A CONSULTING PUBLIC POLICY FIRM USED BY THE INSTITUTE. X EQUIPMENT 48 1498283 PURCHASE PRICE 0 0 0 0 Part I, Column (b): THE NUMBER ON LINE 25(B) REPRESENTS THE NUMBER OF ITEMS CONTRIBUTED, NOT THE NUMBER OF CONTRIBUTIONS. Form 990, Part VI, Section A, line 2 THE FOLLOWING DIRECTORS AND OFFICERS, THAT JOINTLY SERVE ON THE INSTITUTE AND A FOR-PROFIT RELATED ENTITY, QUALIFY AS HAVING A BUSINESS RELATIONSHIP. INSTITUTE & MOFFITT GENETICS CORPORATION: THEODORE J. COUCH, DIRECTOR & OFFICER SENATOR CONNIE MACK, DIRECTOR & OFFICER ROBERT ROTHMAN, DIRECTOR & OFFICER H. LEE MOFFITT, DIRECTOR LOUIS D. DE LA PARTE, OFFICER JOHN A KOLOSKY, OFFICER YVETTE LYONS TREMONTI, OFFICER DANIEL M. SULLIVAN, OFFICER WILLIAM S.DALTON, OFFICER INSTITUTE & MOFFITT TECHNOLOGIES CORPORATION: ALAN F. LIST, DIRECTOR AND OFFICER JOHN A. KOLOSKY, OFFICER LOUIS D. DE LA PARTE, OFFICER YVETTE LYONS TREMONTI, OFFICER JAMES J. MULAY, OFFICER Form 990, Part VI, Section B, line 11 LINE 11B, PRIOR TO PROVIDING FORM 990, RETURN OF ORGANIZATION EXEMPT FROM INCOME TAX, TO THE PARENT-RESEARCH BOARD OF DIRECTORS FOR REVIEW, THE CHIEF FINANCIAL OFFICER REVIEWS THE RETURN. SUGGESTED COMMENTS OR CHANGES ARE DISCUSSED AND ANY NECESSARY CORRECTIONS ARE MADE. PRIOR TO ELECTRONICALLY FILING FORM 990, MOFFITT PARENT-RESEARCH PROVIDES A COPY OF THE RETURN TO THE GOVERNING BODY, GIVING EACH BOARD MEMBER TIME TO REVIEW THE RETURN. BOARD MEMBERS HAVE THE OPPORTUNITY TO ASK QUESTIONS RELATED TO THE INFORMATION PROVIDED ON THE RETURN. Form 990, Part VI, Section B, line 12c ON AN ANNUAL BASIS A PRESENTATION IS MADE TO RESEARCH BOARD MEMBERS TO REVIEW THE CONFLICT OF INTEREST POLICY AND PROCEDURES FOR DISCLOSING ANY POTENTIAL CONFLICTS. EACH DIRECTOR, OFFICER, COMMITTEE MEMBER, AND KEY EMPLOYEE SHALL COMPLETE A CONFLICT OF INTEREST DISCLOSURE FORM ATTACHED TO THE POLICY. ANY DIRECTOR, OFFICER, COMMITTEE MEMBER, OR KEY EMPLOYEE WHO REASONABLY BELIEVES THAT HE OR SHE MAY HAVE AN ACTUAL OR POTENTIAL CONFLICT OF INTEREST MUST DISCLOSE THE EXISTENCE OF AND THE MATERIAL FACTS OF THE NATURE OF HIS/HER INTEREST ON THE FORM. THE FORM IS SUBMITTED TO THE CORPORATE COMPLIANCE OFFICE, WHICH REVIEWS THE FORMS, GATHERS ADDITIONAL RELEVANT INFORMATION WHERE NECESSARY, AND PREPARES A SUMMARY OF THE DISCLOSURES TO BE REVIEWED BY THE CONFLICT OF INTEREST WORK GROUP. IF A DIRECTOR OR COMMITTEE MEMBER DISCLOSES THAT HE/SHE HAS A POTENTIAL CONFLICT OF INTEREST AT A BOARD OR COMMITTEE MEETING, SUCH DIRECTOR OR COMMITTEE MEMBER MUST DISCLOSE THE NATURE OF THE INTEREST AND ANY RELATED INFORMATION AND RESPOND TO QUESTIONS AS MAY BE REQUIRED BY THE REMAINING MEMBERS. BASED ON THE INFORMATION DISCLOSED, THE REMAINING BOARD MEMBERS WILL DETERMINE WHETHER A CONFLICT OF INTEREST EXISTS. IF A CONFLICT EXISTS THE BOARD OR COMMITTEE SHALL DETERMINE WHETHER AN ALTERNATIVE TRANSACTION OR ARRANGEMENT THAT WOULD NOT GIVE RISE TO A CONFLICT IS EQUALLY ADVANTAGEOUS. IF AN ALTERNATIVE TRANSACTION IS NOT EQUALLY ADVANTAGEOUS THE DIRECTOR OR COMMITTEE MEMBER WHO IS THE SUBJECT OF THE CONFLICT SHALL NOT VOTE ON, NOR USE HIS/HER PERSONAL INFLUENCE ON, NOR PARTICIPATE IN DISCUSSIONS OR DELIBERATIONS WITH RESPECT TO THE TRANSACTION. Form 990, Part VI, Section B, line 15 MOFFITT'S BOARD OF DIRECTORS HAS AN ESTABLISHED SUB-COMMITTEE, THE JOINT EXECUTIVE COMPENSATION & BENEFITS COMMITTEE (JEC&BC) THAT IS MADE UP ENTIRELY OF INDEPENDENT, OUTSIDE DIRECTORS. THIS COMMITTEE IS CHARGED WITH THE OVERSIGHT OF THE PERFORMANCE AND COMPENSATION OF MOFFITT EXECUTIVES AND DISQUALIFIED PERSONS. THESE POSITIONS INCLUDE THE CEO, EXECUTIVE VICE PRESIDENTS, SENIOR VICE PRESIDENTS, VICE PRESIDENTS AND DEPARTMENT CHAIRPERSONS. TO ACCOMPLISH ITS MISSION, THE COMMITTEE CAN AS NEEDED AND DOES AT ITS DISCRETION, ENGAGE OUTSIDE INDEPENDENT, OUTSIDE ADVISORS INCLUDING, BUT NOT LIMITED TO ATTORNEYS AND COMPENSATION CONSULTANTS. ON AN ANNUAL BASIS THE JEC&BC ENGAGES A NATIONALLY KNOWN, THIRD PARTY CONSULTING FIRM TO PROVIDE A DETAILED STUDY OF THE CASH COMPENSATION FOR EACH EXECUTIVE, DISQUALIFIED PERSON AND INDIVIDUAL IN KEY POSITIONS. THE CONSULTANT USES A VARIETY OF PUBLISHED SURVEYS COMPILED BY INDEPENDENT FIRMS TO PROVIDE THE SOURCE DATA FOR THE STUDY. USING FUNCTIONALLY COMPARABLE POSITIONS IN OTHER SIMILARLY SIZED, NOT-FOR-PROFIT AND FOR-PROFIT HEALTHCARE, ACADEMIC AND RESEARCH ORGANIZATIONS, THE CONSULTING FIRM PRODUCES A STUDY THAT COMPARES EACH DESIGNATED MOFFITT POSITION TO ITS APPROPRIATE MARKET EQUIVALENT. THE RESULTING DATA IS PROVIDED TO THE DIRECTOR OF COMPENSATION, WHO IS NOT INCLUDED IN THE EXECUTIVE OR DISQUALIFIED PERSON CATEGORIES, FOR USE IN THE FORMULATION OF RECOMMENDATIONS FOR COMPENSATION CHANGES TO MAINTAIN MARKET COMPETITIVENESS OR TO REWARD PERFORMANCE. THESE RECOMMENDATIONS ALONG WITH THE CONSULTANT'S COMPARABILITY DATA ARE PRESENTED TO THE JEC&BC FOR IT TO CONFIRM ITS REASONABLENESS, MAKE MODIFICATIONS AS IT DEEMS NECESSARY AND PROVIDE FINAL APPROVAL. EVERY THIRD YEAR THE INDEPENDENT CONSULTANT ANALYZES THE TOTAL EXECUTIVE COMPENSATION PROGRAM, USING THE SAME METHODOLOGY AS DESCRIBED ABOVE, THAT INCLUDES THE VALUE OF ALL BENEFITS AND PREREQUISITES (CASH AND NON-CASH) PROVIDED AS COMPENSATION TO THE EXECUTIVES AND DISQUALIFIED PERSONS. THE PURPOSE OF THE ANALYSIS IS TO PROVIDE AN OPINION ON THE REASONABLENESS OF EACH OF THE INDIVIDUAL COMPENSATION COMPONENTS AND THE AGGREGATE COMPENSATION TOTAL. THIS MORE COMPREHENSIVE ANALYSIS IS PROVIDED TO THE JEC&BC FOR THEIR USE IN THE ANNUAL REVIEW PROCESS. MINUTES ARE KEPT AT EACH OF THESE ANNUAL MEETINGS DETAILING THE RECOMMENDATIONS PRESENTED AND THE DECISIONS MADE BY THE COMMITTEE. THESE MINUTES ARE PUBLISHED TO THE COMMITTEE AT THE NEXT MEETING AND REPORTED BACK TO THE FULL BOARD. Form 990, Part VI, Section C, line 19 MOFFITT RESEARCH MAKES AVAILABLE TO THE PUBLIC THROUGH THIRD PARTY VENDORS' WEBSITES, ITS FORM 990 AND AUDITED FINANCIAL STATEMENTS. FORM 990 IS MADE AVAILABLE ON GUIDESTAR WHILE THE AUDITED FINANCIAL STATEMENTS ARE MADE AVAILABLE ON DACBOND. ALL ORGANIZING AND GOVERNING DOCUMENTS SUCH AS FORM 1023, CONFLICTS OF INTEREST POLICY, AND BYLAWS AS WELL AS FORM 990 AND AUDITED FINANCIAL STATEMENTS ARE MADE AVAILABLE UPON REQUEST. Form 990, Part VI, Section B, Line 16b: THE ORGANIZATION HAS ADOPTED A WRITTEN JOINT VENTURE PROCEDURE WITH WHICH IT COMPLIES, BUT HAS NOT BEEN BOARD APPROVED. PARENT/RESEARCH HAS ONE JOINT VENTURE AGREEMENT WITH PREMIER PURCHASING PARTNERS WHICH HAS BEEN IN EFFECT PRIOR TO 2008 AND RENEWED AT THE END OF 2014. FORM 990, PART VII, SECTION A INCLUDED IN ALAN LIST'S COMPENSATION IS A ROYALTY PAYMENT RELATED TO A RESEARCH INVENTION IN THE AMOUNT OF $ 1,503,462. Form 990, Part IX, Column (D): THERE ARE NO FUNDRAISING EXPENSES BECAUSE THE CONTRIBUTIONS ARE FROM RELATED ORGANIZATIONS, GOVERNMENT GRANTS, AND OTHER GRANTS. H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE FOUNDATION, INC. HANDLES ALL FUNDRAISING ACTIVITIES FOR H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. AND ITS SUBSIDIARIES. Form 990, Part XI, line 9: PREMIER PARTNERSHIP INCOME -940871. INTEREST IN NET ASSETS OF FOUNDATION -403105. TRANSFER FROM TAX EXEMPT AFFILIATE 35746058. GRANT REFUNDS -267740. NONCASH CONTRIBUTION INCLUDED IN REV ON 990, BUT NOT AUDITED FINANCIAL STMT -202978. NET ASSETS RELEASED FROM RESTRICTION -1651289. H LEE MOFFITT CANCER CTR & RESEARCH INSTITUTE HOSPITAL INC 12902 MAGN0LIA DRIVE TAMPA FL 33612 593238634 PATIENT CARE FL 501(c)(3) Line 3 N/A 1 H LEE MOFFITT CANCER CTR & RESEARCH INSTITUTE FOUNDATION INC 12902 MAGN0LIA DRIVE TAMPA FL 33612 593238636 FUNDRAISING FL 501(c)(3) Line 7 H LEE MOFFITT CANCER CTR & RES INST INC 1 H LEE MOFFITT CC&RI LIFETIME CANCER SCREENING CENTER INC 12902 MAGN0LIA DRIVE TAMPA FL 33612 593238640 PRACTICE MANAGEMENT FL 501(c)(3) Line 9 H LEE MOFFITT CANCER CTR & RES INST INC 1 MOFFITT TECHNOLOGIES CORPORATION 12902 MAGNOLIA DRIVE TAMPA FL 33612 300332914 TECHNOLOGY MANAGEMENT FL H LEE MOFFITT CC&RI INC C -1128 264505 1.00000 1 MOFFITT GENETICS CORPORATION 10902 N MCKINLEY DRIVE TAMPA FL 33612 208486180 DATABASE MANAGEMENT FL H LEE MOFFITT CC&RI INC C -5305818 28164020 1.00000 1 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 MOFFITT GENETICS CORPORATION A 225237 FMV MOFFITT GENETICS CORPORATION A 152860 FMV MOFFITT GENETICS CORPORATION B 243654 FMV H LEE MOFFITT CC&RI HOSPITAL INC B 115071 FMV H LEE MOFFITT CC&RI FOUNDATION INC C 11192430 FMV MOFFITT GENETICS CORPORATION C 2762333 FMV H LEE MOFFITT CC&RI FOUNDATION INC D 3041913 FMV MOFFITT GENETICS CORPORATION D 13921518 FMV MOFFITT GENETICS CORPORATION D 5000000 FMV MOFFITT GENETICS CORPORATION D 43758 FMV MOFFITT GENETICS CORPORATION P 1700482 FMV